{
  "url": "https://openlegislation.uk/branded-health-service-medicines-costs-regulations-2018/schedule-2/paragraph-3",
  "json_url": "https://openlegislation.uk/branded-health-service-medicines-costs-regulations-2018/schedule-2/paragraph-3.json",
  "legislation": "uksi/2018/345",
  "legislation_title": "The Branded Health Service Medicines (Costs) Regulations 2018",
  "legislation_url": "https://openlegislation.uk/branded-health-service-medicines-costs-regulations-2018",
  "path": "schedule/2/paragraph/3",
  "kind": "paragraph",
  "number": "3",
  "heading": null,
  "text": "The manufacturer or supplier referred to in paragraph 1(b) is a manufacturer or supplier that would be required to make payments under regulation 3 or under a direction given under regulation 4 for a period of one or more of their complete accounting reference periods were it not for the fact that regulation 3(6) or 4(5) applied.\nTable 1\nColumn (1)Length of current accounting reference period\nColumn (2)Likely net sales income\nTwelve months\n£6 million\nLess than twelve months\n£6 million as proportionately reduced to the number of months in the manufacturer's or supplier's accounting reference period\nMore than twelve months\n£6 million as proportionately increased to the number of months in the manufacturer's or supplier's accounting reference period\nTable 2\nColumn (1)Length of previous accounting reference period\nColumn (2)Net sales income\nTwelve months\n£6 million\nLess than twelve months\n£6 million as proportionately reduced to the number of months in the manufacturer's or supplier's accounting reference period\nMore than twelve months\n£6 million as proportionately increased to the number of months in the manufacturer's or supplier's accounting reference period",
  "extent": null,
  "status": null,
  "version": "current",
  "annotations": [
    {
      "type": "F",
      "label": "F1",
      "text": "Sum in Sch. 2 para. 3 Table 1 substituted (1.1.2025) by The Branded Health Service Medicines (Costs) (Amendment) Regulations 2024 (S.I. 2024/1277), regs. 1(1), 15"
    },
    {
      "type": "F",
      "label": "F2",
      "text": "Sum in Sch. 2 para. 3 Table 2 substituted (1.1.2025) by The Branded Health Service Medicines (Costs) (Amendment) Regulations 2024 (S.I. 2024/1277), regs. 1(1), 15"
    }
  ],
  "outstanding_effects": [],
  "provenance": {
    "source": "legislation.gov.uk",
    "source_url": "https://www.legislation.gov.uk/uksi/2018/345/schedule/2/paragraph/3",
    "retrieved_at": "2026-10-28T23:00:23.214167+00:00"
  },
  "licence": "Open Government Licence v3.0",
  "licence_url": "https://www.nationalarchives.gov.uk/doc/open-government-licence/version/3/",
  "attribution": "Contains public sector information licensed under the Open Government Licence v3.0. Source: legislation.gov.uk, The National Archives."
}